Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

A critical role for SOCS3 in innate resistance to Toxoplasma gondii.

Whitmarsh RJ, Gray CM, Gregg B, Christian DA, May MJ, Murray PJ, Hunter CA.

Cell Host Microbe. 2011 Sep 15;10(3):224-36. doi: 10.1016/j.chom.2011.07.009.

2.

IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii.

Silver JS, Stumhofer JS, Passos S, Ernst M, Hunter CA.

J Immunol. 2011 Jul 1;187(1):350-60. doi: 10.4049/jimmunol.1004144. Epub 2011 May 23.

3.

IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.

Wille U, Nishi M, Lieberman L, Wilson EH, Roos DS, Hunter CA.

Parasite Immunol. 2004 May;26(5):229-36.

4.

Innate responses to Toxoplasma gondii in mice and humans.

Pifer R, Yarovinsky F.

Trends Parasitol. 2011 Sep;27(9):388-93. doi: 10.1016/j.pt.2011.03.009. Review.

5.

The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii.

Caamaño J, Alexander J, Craig L, Bravo R, Hunter CA.

J Immunol. 1999 Oct 15;163(8):4453-61.

6.

Toll-like receptors and their role in host resistance to Toxoplasma gondii.

Yarovinsky F.

Immunol Lett. 2008 Aug 15;119(1-2):17-21. doi: 10.1016/j.imlet.2008.05.007. Epub 2008 Jun 18. Review.

PMID:
18617274
7.

From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.

Denkers EY.

FEMS Immunol Med Microbiol. 2003 Dec 5;39(3):193-203. Review.

8.

Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.

Béla SR, Dutra MS, Mui E, Montpetit A, Oliveira FS, Oliveira SC, Arantes RM, Antonelli LR, McLeod R, Gazzinelli RT.

Infect Immun. 2012 Dec;80(12):4298-308. doi: 10.1128/IAI.00328-12. Epub 2012 Oct 1.

9.

Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii.

Gorfu G, Cirelli KM, Melo MB, Mayer-Barber K, Crown D, Koller BH, Masters S, Sher A, Leppla SH, Moayeri M, Saeij JP, Grigg ME.

MBio. 2014 Feb 18;5(1). pii: e01117-13. doi: 10.1128/mBio.01117-13.

10.

Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages.

Nakano Y, Hisaeda H, Sakai T, Ishikawa H, Zhang M, Maekawa Y, Zhang T, Takashima M, Nishitani M, Good RA, Himeno K.

Microbes Infect. 2002 Jan;4(1):1-11.

PMID:
11825769
11.

T cell expression of MyD88 is required for resistance to Toxoplasma gondii.

LaRosa DF, Stumhofer JS, Gelman AE, Rahman AH, Taylor DK, Hunter CA, Turka LA.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3855-60. doi: 10.1073/pnas.0706663105. Epub 2008 Feb 28.

12.

Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.

Ge Y, Chen J, Qiu X, Zhang J, Cui L, Qi Y, Liu X, Qiu J, Shi Z, Lun Z, Shen J, Wang Y.

Int J Parasitol. 2014 Jun;44(7):475-84. doi: 10.1016/j.ijpara.2014.03.004. Epub 2014 Apr 13.

PMID:
24727091
13.

NADPH Oxidase and Guanylate Binding Protein 5 Restrict Survival of Avirulent Type III Strains of Toxoplasma gondii in Naive Macrophages.

Matta SK, Patten K, Wang Q, Kim BH, MacMicking JD, Sibley LD.

MBio. 2018 Aug 28;9(4). pii: e01393-18. doi: 10.1128/mBio.01393-18.

15.

Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis.

Carow B, Reuschl AK, Gavier-Widén D, Jenkins BJ, Ernst M, Yoshimura A, Chambers BJ, Rottenberg ME.

PLoS Pathog. 2013;9(7):e1003442. doi: 10.1371/journal.ppat.1003442. Epub 2013 Jul 4.

16.

Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection.

Tu L, Moriya C, Imai T, Ishida H, Tetsutani K, Duan X, Murata S, Tanaka K, Shimokawa C, Hisaeda H, Himeno K.

Eur J Immunol. 2009 Dec;39(12):3385-94. doi: 10.1002/eji.200839117.

17.

Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.

Chen J, Li ZY, Petersen E, Liu WG, Zhu XQ.

Exp Parasitol. 2016 Mar;162:18-23. doi: 10.1016/j.exppara.2015.12.013. Epub 2015 Dec 17.

PMID:
26706605
18.
19.

Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages.

Akhtar LN, Qin H, Muldowney MT, Yanagisawa LL, Kutsch O, Clements JE, Benveniste EN.

J Immunol. 2010 Aug 15;185(4):2393-404. doi: 10.4049/jimmunol.0903563. Epub 2010 Jul 14.

20.

CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites.

Mashayekhi M, Sandau MM, Dunay IR, Frickel EM, Khan A, Goldszmid RS, Sher A, Ploegh HL, Murphy TL, Sibley LD, Murphy KM.

Immunity. 2011 Aug 26;35(2):249-59. doi: 10.1016/j.immuni.2011.08.008.

Supplemental Content

Support Center